Form 4: Moleculin Biotech Executive Receives Stock Grant
Insider Transaction (Form 4)
Donald H Picker, Chief Science Officer of Moleculin Biotech, Inc., received 250,000 shares of common stock on October 15, 2026.
Summary
- Grant/award: acquired 250,000 Stock Options (right to buy) on October 15, 2026; holds 789,595 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Donald H Picker — Officer (Chief Science Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Grant/award | Stock Options (right to buy) | 250,000 | — | — | 789,595 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Grant/award (250,000 shares) |
Keywords
insider transaction, Form 4, MBRX, Moleculin Biotech, Inc., neutral, Donald H Picker
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.